Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Perkins

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|March 1, 1977
Leukocyte migration inhibitory factor (LIF) as an indicator of mixed lymphocyte culture (MLC) reactivityK C Cochrum, O Salvatierra, B L Cullen, et al.
JAMA|August 23, 1971
Survey of blood bank physicians and medical directorsJ A Shively, M Grove-Rasmussen, G J Hummer, et al.
The New England Journal of Medicine|August 5, 1976
Letter: Arteriovenous fistulas for vascular access in patients with hematologic disordersC A Ries, J C Klock, H A Perkins, et al.
Blood|November 1, 1987
Risk of AIDS for recipients of blood components from donors who subsequently developed AIDSH A Perkins, S Samson, J Garner, et al.
Transfusion|January 1, 1991
Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study GroupM P Busch, M J Young, S M Samson, et al.
Lancet (London, England)|July 18, 1970
Modification of donor lymphocytes for transplantation in lymphopenic immunological deficiencyS E Salmon, B A Smith, R I Lehrer, et al.
Lancet (London, England)|April 30, 1983
Acquired immunodeficiency in an infant: possible transmission by means of blood productsA J Ammann, M J Cowan, D W Wara, et al.
American Journal of Diseases of Children (1960)|February 1, 1972
Transplantation of treated lymphocytes in lymphopenic immunologic deficiency. Tritiated thymidine in mixed leukocyte culture for deletion of transplantation antigen responseS E Salmon, S N Mogerman, H A Perkins, et al.
The New England Journal of Medicine|October 12, 1978
Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survivalF Vincenti, R M Duca, W Amend, et al.
Transplantation Proceedings|February 1, 1987
Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipientsN J Feduska, H A Perkins, J Melzer, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|March 1, 1977
Leukocyte migration inhibitory factor (LIF) as an indicator of mixed lymphocyte culture (MLC) reactivityK C Cochrum, O Salvatierra, B L Cullen, et al.
JAMA|August 23, 1971
Survey of blood bank physicians and medical directorsJ A Shively, M Grove-Rasmussen, G J Hummer, et al.
The New England Journal of Medicine|August 5, 1976
Letter: Arteriovenous fistulas for vascular access in patients with hematologic disordersC A Ries, J C Klock, H A Perkins, et al.
Blood|November 1, 1987
Risk of AIDS for recipients of blood components from donors who subsequently developed AIDSH A Perkins, S Samson, J Garner, et al.
Transfusion|January 1, 1991
Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study GroupM P Busch, M J Young, S M Samson, et al.
Lancet (London, England)|July 18, 1970
Modification of donor lymphocytes for transplantation in lymphopenic immunological deficiencyS E Salmon, B A Smith, R I Lehrer, et al.
Lancet (London, England)|April 30, 1983
Acquired immunodeficiency in an infant: possible transmission by means of blood productsA J Ammann, M J Cowan, D W Wara, et al.
American Journal of Diseases of Children (1960)|February 1, 1972
Transplantation of treated lymphocytes in lymphopenic immunologic deficiency. Tritiated thymidine in mixed leukocyte culture for deletion of transplantation antigen responseS E Salmon, S N Mogerman, H A Perkins, et al.
The New England Journal of Medicine|October 12, 1978
Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survivalF Vincenti, R M Duca, W Amend, et al.
Transplantation Proceedings|February 1, 1987
Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipientsN J Feduska, H A Perkins, J Melzer, et al.
Pageof 11